A mission to ‘Do Good’
By Carol Marsh - DarkeCountyMedia.com
Karen Homan (pictured), founder of the Do Good Restaurant and Ministry, located at 25 West Main Street in Osgood, stands by the second floor window which overlooks the activities below.
Carol Marsh | Darke County Media
St. Lawrence Plant, or
Ajuga reptans, also commonly known as Bugleherb, grows by a koi pond in the Do Good ministry courtyard, which also has a prayer walk and a rosary walk, as well as a Children’s Memorial Garden Park, which recently dedicated its Memorial Arch and splash pad.
Carol Marsh | Darke County Media
Lymphangioleiomyomatosis (LAM) Market Research By Growth, Competitive Methods And Forecast To 2027 |
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Dr. Katharina Fitzian, Prof. Dr. Daniel Kümmel, Dr. Andrea Oeckinghaus and Anne Brückner (from left) in their laboratories. The collage in the middle illustrates the structure of the TSC1 membrane. view more
Credit: Kümmel team/Oeckinghaus team
Tuberous Sclerosis Complex (TSC) affects between one and two of every 10,000 new-born babies. This genetic disease leads to the formation of benign tumours which can massively impair the proper functioning of vital organs such as the kidneys, the liver and the brain. The disease affects different patients to varying degrees and is triggered by mutations in one of two genes, the TSC1 or TSC2 gene. An interdisciplinary team of researchers led by biochemists Prof. Daniel Kümmel and Dr. Andrea Oeckinghaus from the University of Münster (Germany) examined the tumour suppressor protein TSC1 and, for the first time, gained insights into its hitherto unclear functions. The team identified a new mechanism, in a cent
Study could help understand how Tuberous Sclerosis Complex arises
Tuberous Sclerosis Complex (TSC) affects between one and two of every 10,000 new-born babies. This genetic disease leads to the formation of benign tumors which can massively impair the proper functioning of vital organs such as the kidneys, the liver and the brain. The disease affects different patients to varying degrees and is triggered by mutations in one of two genes, the TSC1 or TSC2 gene.
An interdisciplinary team of researchers led by biochemists Prof. Daniel Kümmel and Dr. Andrea Oeckinghaus from the University of Münster (Germany) examined the tumor suppressor protein TSC1 and, for the first time, gained insights into its hitherto unclear functions. The team identified a new mechanism, in a central cellular process, which regulates cell growth. The results can also help in understanding how Tuberous Sclerosis Complex arises. The results of the study have now been published in the journal